ClinicalTrials.gg
RecruitingNCT07591792Updated Nov 16, 2026

Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation

An observational study in Heart Disease and COPD, sponsored by Nordsjaellands Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Nordsjaellands Hospital · Observational

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 16, 2026Now RecruitingFirst site in Denmark+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
840
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 80 studies in Heart Diseases with a site in Denmark — 17 open to participants now, 30 under way, 3 of them phase 3. Heart Diseases · Denmark.

Planned enrollment
6th of 16
840 · median 282
Started
2026
with 1 other
Observational
16 of 80
5 open now
Primary completion
2029-03
later than 23 of 29 live
Registered
80th of 80
by date

Among the 80 studies in Heart Diseases with a site in Denmark, this one is the 6th largest by planned enrollment of the 16 observational ones that give a count, is one of 2 that started in 2026, is one of 16 observational ones, reaches primary completion later than 23 of the 29 other live ones, and was the 80th registered.

Heart Diseases

2,135 studies on the registry are indexed under Heart Diseases; 250 are open to participants now.

Browse Heart Diseases studies →

Open to participants now

17 of the 80 studies in Heart Diseases with a site in Denmark are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 182 Heart Diseases studies recruiting now, 128 (70%) set no upper age limit and 22 (12%) stop at 75 or younger; 33 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 80 studies in Heart Diseases with a site in Denmark, or all of them as a file.
02

Study summary

Aim The aim of this project is to investigate the level of participation, satisfaction, changes in tests, and factors associated with these results in existing rehabilitation programmes at North Zealand Hospital and in the surrounding municipalities among patients with heart diseases and the lung disease chronic obstructive pulmonary disease (COPD). The project is conducted in clinical practice in a non-selected population.

Participants Individuals with heart disease and COPD who commence training at North Zealand Hospital. Up to 840 participants may be included over a two-year period. Participants will be recruited at the start of training at North Zealand Hospital.

Inclusion criteria:

Patients from North Zealand Hospital (Hillerød and Frederikssund) referred with a rehabilitation plan for group-based rehabilitation for heart disease or COPD at North Zealand Hospital Patient consent to participate in the project. There are no exclusion criteria for the project.

Intervention Participants will be invited to participate in the project when enrolling in the already existing group-based training programme lasting 6-10 weeks as part of rehabilitation for heart disease and COPD.

Data

Participation:

Number of patients commencing the training period relative to the number of patients referred from the cardiology department

Attendance:

Number of completed training sessions relative to the total number of possible training sessions during the periods at the hospital and in the municipalities

Dropout:

Dropout during the hospital-based and municipality-based periods and reasons for dropout The data listed below will, as far as possible, be collected before and after the training period. Physical activity (the final variable) will additionally be measured three months after completion of the municipal programme.

30-second sit-to-stand test* Six-minute walk test* Quality of life measured using the CAT questionnaire for COPD and EQ-5D for the two groups of patients with heart disease Musculoskeletal pain measured using a questionnaire with the Numeric Rating Scale for five body regions Physical activity measured using a modified version of the IPAQ questionnaire from the Danish Health and Morbidity Surveys

*These tests are standard and implemented in the existing rehabilitation programmes.

Other Data

Additional data will include:

From questionnaire: educational level and BMI (height and weight) From patient records: age, sex, treatment for heart disease, and extent of other chronic diseases Data from patient records are already collected as part of routine clinical practice independently of this project.

Ethics Participants will be invited to the study with written and oral information. Participation will take place after informed consent. The study will be conducted in accordance with the regulations of the Scientific Ethical Committee, to which it will be submitted as soon as possible, and it will be reported in the Capital Region of Denmark's legal system via PRIVACY. The study will be registered in the project database www.clinicaltrials.gov. Data will be stored in the REDCap database system.

Dissemination of Results Results will be presented at local and regional meetings and symposia and published in international peer-reviewed scientific journals indexed in PubMed.

Read the detailed description

Following standard referral after diagnosis of myocardial ischemia, heart failure, or COPD, patients are offered structured outpatient rehabilitation programmes in which supervised physical exercise is a key component. Depending on diagnosis and risk stratification, rehabilitation is delivered at North Zealand Hospital and/or in collaborating municipalities.

This prospective intervention study without a control group is conducted in routine clinical practice. Participants are invited when they enroll in existing group-based rehabilitation programmes. The intervention itself is not experimental and follows standardized, implemented rehabilitation protocols.

Patients with myocardial ischemia and heart failure participate in six weeks of supervised group-based exercise at the hospital, twice weekly, followed by six weeks of rehabilitation in municipal settings. Patients with COPD participate in group-based exercise for up to 12 weeks delivered at the hospital or via telerehabilitation. Exercise sessions include warm-up, aerobic interval training, light resistance training for major muscle groups, and stretching, with intensity guided by the Borg Rating of Perceived Exertion scale.

The primary focus of the study is participation (enrollment, attendance, and dropout) and satisfaction with rehabilitation. Secondary outcomes include changes in physical function, quality of life, musculoskeletal pain, and physical activity. Measurements are obtained before and after the hospital-based rehabilitation period, after any municipal rehabilitation period, and for physical activity additionally at three months after completion.

Sociodemographic and clinical variables obtained from questionnaires and patient records are used to examine factors associated with participation, dropout, and changes in outcomes. The study aims to generate real-world evidence to support optimization of rehabilitation delivery and continuity across healthcare sectors.

Study Type Observational Patient Registry / Prospective Cohort

Conditions

Myocardial Ischemia Heart Failure Chronic Obstructive Pulmonary Disease (COPD)

Interventions Intervention Type: Other Intervention Name: Standard outpatient exercise-based rehabilitation Description: Standardized, guideline-based group exercise programmes delivered as part of routine cardiac and pulmonary rehabilitation (hospital-based, municipal-based, and telerehabilitation).

Outcome Measures Participation and adherence Enrollment rate, attendance rate, and dropout during hospital- and municipality-based rehabilitation Time frame: Up to 12 weeks Satisfaction with rehabilitation (questionnaire) Time frame: End of hospital-based rehabilitation and follow-up 30-second sit-to-stand test Six-minute walk test Time frame: Baseline, post-rehabilitation, and follow-up Quality of life EQ-5D (heart disease) COPD Assessment Test (CAT) Time frame: Baseline, post-rehabilitation, follow-up Musculoskeletal pain Numeric Rating Scale (five body regions) Time frame: Baseline, post-rehabilitation, follow-up Physical activity level Modified IPAQ questionnaire Time frame: Baseline, post-rehabilitation, and three months after completion

Eligibility Criteria Inclusion Criteria Adults referred from North Zealand Hospital (Hillerød or Frederikssund) with a rehabilitation plan for group-based rehabilitation for myocardial ischemia, heart failure, or COPD Enrollment in standard outpatient rehabilitation Provided informed consent Exclusion Criteria None

Enrollment Estimated enrollment: 840 participants

03

Conditions studied

  • Heart Disease
  • COPD

Keywords

  • heart disease
  • COPD
  • Exercise training
  • Physical activity
  • Physical function
  • Quality of life
  • Muscoloskeletal pain
  • Adherence
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with heart disease or the lung disease COPD refered to out-patient exercise training during rehabilitation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients from North Zealand Hospital (Hillerød and Frederikssund) referred with a rehabilitation plan for group-based rehabilitation for myocardial ischemia, heart failure, or at North Zealand Hospital
  • Patient consent to participate in the project

Exclusion criteria

Exclusion Criteria:

  • None
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
840 participants (estimated)
Target follow-up
26 Weeks
Patient registry
Yes

Groups and cohorts

  • Rehabilitation group

    Patients with heart disease or COPD that are referred to exercise training in a rehabilitation program

06

What researchers measure

Primary outcomes

  1. Six minutes walk test

    Distance walked in six minutes

    Time frame: from baseline to six weeks and 12 weeks

Secondary outcomes

  1. 30 sec chair stand test

    Number of repetitions of rises from a chair in 30 sec

    Time frame: Baseline to six weeks and 12 weeks

  2. EuroQol 5-Dimension

    Quality of life questionaire with index scores from 0-1 and visual analog scale from 0-100, where higher score indicates better health in both

    Time frame: Baseline to 12 weeks

  3. Muscoloskeletal pain

    Muscoloskeletal pain in five body sites Numeric Rating Scale 0-10

    Time frame: Baseline to six weeks and 12 weeks

  4. Physical activity

    Questionaire fra the Danish Health and Morbidity Survey

    Time frame: From baseline to 24 weeks

Other outcomes

  1. Adherence to the training intervention registration

    Training intervention adherence registered as participation relative to scheduled training sessions in percentage

    Time frame: Baseline to 12 weeks

  2. Dropout of the training intervention

    Participations' dropout during the training intervention period

    Time frame: Baseline to 12 weeks

  3. Satisfaction with treatment questionaire

    Satisfaction with intervention assessed using a local questionaire with five questions that are replyed from 1-5 where higher score is more agree

    Time frame: Baseline to 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • References 1 Dibben GO, Faulkner J, Oldridge N, et al.: Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. European Heart Journal 2023;44:452.doc:695b90bef87f303feb9c923b1(6) 2 Molloy CD, Long L, Mordi IR, et al.: Exercise-based cardiac rehabilitation for adults with heart failure - 2023 Cochrane systematic review and meta-analysis. European J of Heart Fail 2023;25:2263.doc:695b92b8f87f303feb9c92441(12) 3 Shields GE, Wells A, Doherty P, et al.: Cost-effectiveness of cardiac rehabilitation: a systemat-ic review. Heart 2018;104:1403.doc:695ba4b47d51ae13acc1ab991(17) 4 Tian X, Liu F, Li F, et al.: A Network Meta-Analysis of Aerobic, Resistance, Endurance, and High-Intensity Interval Training to Prioritize Exercise for Stable COPD. COPD 2024;Volume19:2035.doc:695b96e2bcf8ef34cffa42a91 5 Liu S, Zhao Q, Li W, et al.: The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review. Appl Health Econ Health Policy 2020;19:313.doc:695ba5d16976963cbb24f1161(3) 6 DHRD Årsrapport 2024:doc:695ba9757d51ae13acc1aec91 7 Sommer CG, Jorgensen LB, Blume B, et al. Dropout during a 12-week transitional exercise-based cardiac rehabilitation programme: a mixed-methods prospective cohort study. Eur J Car-diovasc Nurs 2022,21(6):578-86. 8 Ibsen C, Katholm KK, Jakobsen A, et al. Reducing dropout rates in cardiac rehabilitation among cardiac patients in a vulnerable situation: systematic development and feasibility testing of the Heart Priority Programme. BMC Health Serv Res 2024,24(1):1579-x. 9 Mikkelsen T, Korsgaard Thomsen K, Tchijevitch O. Non-attendance and drop-out in cardiac rehabilitation among patients with ischaemic heart disease. Dan Med J 2014,61(10):A4919. 10 Damlund ARS, Jorgensen LB, Blume B, et al. Reasons for dropout in the transition from hospital to municipality during exercise-based cardiac rehabilitation in a Danish cross-sectorial setting: a qualitative study. BMJ Open 2022,12(11):e064660-064660. 11 St

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Mar 2029, 31 months after the start.

Of 185 non-industry observational studies under Heart Diseases, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 118. This study's planned 31 months is below that.

Counting every sponsor, half of 239 studies reached it within 46 months; a quarter within 18 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2026
First posted
May 18, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Mar 1, 2029
CompletionEst.
Jun 30, 2029
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 16, 2026
Sites
1 site added — first site in Denmark
Show site
  • Copenhagen University Hospital - North Zealand · Hillerød, Denmark
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Denmark
    Show site
    • Copenhagen University Hospital - North Zealand · Hillerød, Denmark
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07591792
Lead sponsor
Nordsjaellands Hospital
Responsible party
Stig Molsted (Associate Professor, Nordsjaellands Hospital) — Principal investigator
First posted
May 18, 2026
Start date
Aug 1, 2026
Primary completion
Mar 1, 2029 (estimated)
Completion
Jun 30, 2029 (estimated)
Last update
Nov 16, 2026

Study contacts

Stig Molsted, PhD
Contact
stig.moelsted@regionh.dk
004531959849

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion